TITLE

Combination ACE inhbitor and angiotensin-receptor blocker therapy was better than monotherapy in nondiabetic renal disease

AUTHOR(S)
Weise, Wolfgang J.
PUB. DATE
September 2003
SOURCE
ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p40
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study that compared the effectiveness of a combination of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker therapy with a monotherapy in treating nondiabetic renal disease. Design; Intervention; Outcome measures; Results; Commentary.
ACCESSION #
10987124

 

Related Articles

  • Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease. Omae, Kiyotsugu; Ogawa, Tetsuya; Nitta, Kosaku // Heart & Vessels;May2010, Vol. 25 Issue 3, p203 

    Angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) is recommended for the treatment of hypertension in patients with chronic kidney disease (CKD). The relation of ACEI to renal prognosis was investigated in CKD patients in a retrospective cohort study. The...

  • Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-up. Lama, Giuliana; Salsano, Maria Esposito; Pedulla’, Marcella; Grassia, Carolina; Ruocco, Giuseppe // Pediatric Nephrology;1997, Vol. 11 Issue 6, p714 

    We evaluated the effect of 2 years' therapy with an angiotensin converting enzyme inhibitor (captopril) in 16 patients who had severe reflux nephropathy and microalbuminuria. During the period of therapy, microalbuminuria decreased, glomerular filtration rate measured by diethylenetriamine...

  • Benazepril plus amlodipine combination slowed progression to nephropathy. Brannon, Matthew // Endocrine Today;Mar2010, Vol. 8 Issue 3, p16 

    The article reports on the finding that a combination of the angiotensin-converting enzyme inhibitor benazepril and the calcium-channel blocker amlodipine may be effective in slowing the progression of chronic kidney disease.

  • Low-Dose Ramipril Safely Prevents Proteinuria.  // Kidney;Nov/Dec99, Vol. 8 Issue 6, p264 

    Tests the hypothesis that the impact of angiotensin-converting enzyme (ACE) inhibitors on plasma potassium could be minimized in patients with chronic renal disease and proteinuria by using very low doses. Effect of low-dose oral ramipril on plasma potassium in adult patients with proteinuria...

  • ACE inhibitors benefit the kidneys, independent of BP-lowering.  // Modern Medicine;Jul95, Vol. 63 Issue 7, p23 

    Reports on the benefits offered by angiotensin-converting enzyme (ACE) inhibitors to patients with renal disease according to a study published in the May 22, 1995 issue of the `Archives of Internal Medicine.' Reducing proteinuria; Improving glomerular filtration rate; Efficacy in lowering mean...

  • Diabetics draw an ACE.  // Consumer Reports on Health;Apr94, Vol. 6 Issue 4, p41 

    Focuses on the medical value of angiotensin converting enzyme (ACE) inhibitors in the prevention of kidney damaged caused by diabetes. Result of the research on people with type I diabetes; Prevention process of ACE inhibitors.

  • Angiotensin Converting Enzyme Inhibitors and Progressive Renal Insufficiency. Keane, William F.; Anderson, Sharon; Aurell, Mattias; de Zeeuw, Dick; Narins, Robert G.; Povar, Gail // Annals of Internal Medicine;9/15/89, Vol. 111 Issue 6, p503 

    Analyzes the rationale for using angiotensin converting enzyme (ACE) inhibitors in progressive renal disease. Evaluation of the experience with ACE inhibitors in patients with hypertension and renal insufficiency; Factors in the progression of renal disease; Description of glomerular...

  • SCLERODERMA RENAL CRISIS. Steen, Virginia // Indian Journal of Medical Sciences;Feb2007, Vol. 61 Issue 2, p71 

    The article presents information on a report concerning scleroderma renal crisis (SRC). The disease is considered as the most deadly scleroderma complication which can be treated with the use of angiotensin converting enzyme inhibitors. The article includes information concerning the risk...

  • Strategies to delay renal deterioration. Solomon, Richard; D'Epiro, Nancy Walsh // Patient Care;2/15/1995, Vol. 29 Issue 3, p50 

    Discusses techniques to delay renal deterioration in diabetic patients. Use of angiotensin-converting enzyme (ACE) inhibitors; Screening guidelines for microalbuminuria; Importance of glucose control and lowering lipid levels.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics